Literature DB >> 8611880

Pravastatin: interaction with oral anticoagulant?

T Trenque1, H Choisy, M L Germain.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611880      PMCID: PMC2350580          DOI: 10.1136/bmj.312.7035.886b

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  3 in total

1.  Frequency and significance of late evolution of Q waves in patients with initial non-Q-wave acute myocardial infarction. Diltiazem Reinfarction Study Group.

Authors:  R E Kleiger; W E Boden; K B Schechtman; R S Gibson; D J Schwartz; B J Geiger; R J Capone; R Roberts
Journal:  Am J Cardiol       Date:  1990-01-01       Impact factor: 2.778

Review 2.  [Side effects of cholesterol synthesis inhibitors].

Authors:  R Wolterbeek; B H Stricker
Journal:  Ned Tijdschr Geneeskd       Date:  1993-05-08

Review 3.  Pravastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

  3 in total
  3 in total

Review 1.  Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.

Authors:  David Williams; John Feely
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Pharmacodynamic evaluation of warfarin and rosuvastatin co-administration in healthy subjects.

Authors:  Daisy Jindal; Monika Tandon; Sanjay Sharma; K K Pillai
Journal:  Eur J Clin Pharmacol       Date:  2005-10-19       Impact factor: 2.953

Review 3.  Pravastatin. A reappraisal of its pharmacological properties and clinical effectiveness in the management of coronary heart disease.

Authors:  M Haria; D McTavish
Journal:  Drugs       Date:  1997-02       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.